LILRB2 and neoplasm: Furthermore, HLA class I deficient B6-F10 tumor growth has been reported to be suppressed in immunodeficient non-obese diabetic (NOD)-scid IL2Rgammanull mice, although LILRB2 gene deficiency did not enhance CD47 disruption-mediated cancer cell phagocytosis in vitro [211].